@article{c490159cff3944d297283015cc40e687,
title = "Endogenous serum erythropoietin and no-reflow in patients with ST-elevation myocardial infarction",
abstract = "In models of acute ischaemia, erythropoietin (EPO) administration has been found to attenuate vascular injury largely through reduced apoptosis, suppressed inflammation and increased nitric oxide availability. We studied the association between circulating endogenous EPO and no-reflow in patients with first ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PPCI).",
keywords = "Aged, Biological Markers, Coronary Angiography, Electrocardiography, Erythropoietin, Female, Humans, Male, Middle Aged, Myocardial Infarction, No-Reflow Phenomenon, Regression Analysis, Aged, Biological Markers, Coronary Angiography, Electrocardiography, Erythropoietin, Female, Humans, Male, Middle Aged, Myocardial Infarction, No-Reflow Phenomenon, Regression Analysis",
author = "Giampaolo Niccoli and Felicita Andreotti and Francesca Marzo and Silvia Cecchetti and Eleonora Santucci and Domenico D'Amario and Teodosio Pafundi and Nicola Cosentino and Filippo Crea",
year = "2011",
doi = "10.1111/j.1365-2362.2011.02528.x",
language = "English",
volume = "41",
pages = "1210--1219",
journal = "European Journal of Clinical Investigation",
issn = "0014-2972",
publisher = "Blackwell Science Limited:PO Box 88, Oxford OX2 0NE United Kingdom:011 44 1865 776868, 011 44 1865 206038, EMAIL: journals.cs@blacksci.co.uk, INTERNET: http://www.blackwell-science.com, Fax: 011 44 1865 721205",
}